Stock Events

Stock Events

Search...

Lineage Cell Therapeutics (LCTX.TA) Q4 2023 Earnings

7MarConfirmed

Q4 2023

-0.04

-0.04

-0.03

-0.03

Details

Expected EPS

-0.042857

Actual EPS

-0.03

Surprise EPS

0.01

Surprise Percent

+30%

Description

Lineage Cell Therapeutics (LCTX.TA) has reported earnings of -0.03 per share for Q4 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.